NPI: 1679878268 · LUBBOCK, TX 79424 · 2083P0011X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 4,323 | $15K |
| 2019 | 7,489 | $33K |
| 2020 | 8,240 | $65K |
| 2021 | 8,174 | $105K |
| 2022 | 8,585 | $131K |
| 2023 | 17,991 | $466K |
| 2024 | 12,876 | $297K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99233 | Prolong inpt eval add15 m | 13,875 | 2,148 | $285K |
| 99214 | 8,110 | 5,193 | $171K | |
| 99232 | 16,560 | 3,388 | $131K | |
| 11042 | 5,845 | 2,530 | $124K | |
| 99213 | 7,197 | 4,211 | $79K | |
| 93925 | 789 | 610 | $53K | |
| 93970 | 793 | 591 | $51K | |
| 93306 | 592 | 521 | $49K | |
| 99309 | 5,132 | 1,831 | $34K | |
| 99223 | Prolong inpt eval add15 m | 668 | 593 | $29K |
| 99204 | 528 | 409 | $21K | |
| 93880 | 326 | 262 | $18K | |
| 99308 | 3,475 | 1,463 | $18K | |
| 93922 | 439 | 348 | $13K | |
| 99222 | 467 | 430 | $11K | |
| 93000 | 964 | 787 | $6K | |
| 93015 | 135 | 125 | $6K | |
| 99203 | 47 | 45 | $2K | |
| 99212 | 288 | 186 | $2K | |
| 93926 | 42 | 30 | $2K | |
| 97597 | 212 | 133 | $1K | |
| 78452 | 16 | 15 | $1K | |
| A9502 | Tc99m tetrofosmin | 16 | 15 | $982.06 |
| 99231 | 279 | 72 | $915.04 | |
| J2785 | Regadenoson injection | 16 | 15 | $826.18 |
| 99305 | 46 | 29 | $526.37 | |
| 99426 | 33 | 33 | $136.95 | |
| 99458 | 12 | 12 | $90.09 | |
| 0640T | 446 | 96 | $88.32 | |
| 99427 | 18 | 18 | $74.63 | |
| 99457 | 12 | 12 | $36.49 | |
| J1100 | Dexamethasone sodium phos | 63 | 31 | $3.12 |
| G8427 | Docrev cur meds by elig clin | 70 | 67 | $0.00 |
| G8752 | Sys bp less 140 | 34 | 32 | $0.00 |
| G8598 | Asa/antiplat ther used | 12 | 12 | $0.00 |
| 99306 | Prolong nursin fac eval 15m | 18 | 17 | $0.00 |
| 1036F | 31 | 29 | $0.00 | |
| G8420 | Calc bmi norm parameters | 16 | 15 | $0.00 |
| G8754 | Dias bp less 90 | 56 | 52 | $0.00 |